950.00 AED
Offer a comprehensive and personalized view of cancer statusby analyzing CTCs and providing count of CTCs, phenotype markers and stemness markers
Who should opt for this test:
Oncotrace is an important step in the management and follow-up of a cancer treatment regimen. At the initial phase of the diagnosis of cancer, it gives us information on the current CTC count as well as the profile of how aggressive these cells are through the study of the Cancer Stem Cell (CSC) markers.
By studying cancer behavior at a molecular level, doctors and patients can monitor the activity of tumor markers responsible for migration, proliferation, resistance, and metastasis.
Offer a comprehensive and personalized view of cancer statusby analyzing CTCs and providing count of CTCs, phenotype markers and stemness markers
Who should opt for this test:
